OrbiMed Advisors

OrbiMed Advisors LLC is a private equity and venture capital firm specializing in buyouts, seed, startups, early stage, emerging growth, middle market, mid venture, late venture, incubation, PIPES, and growth capital investments. It primarily provides its services to pooled investment vehicles, U.S.-registered Investment Company, various types of institutions, and a number of investment funds. The firm manages mutual, hedge, royalty and debt funds, venture capital, public and private equity funds for its clients. It invests in the public equity, fixed income, and alternative investment markets across the globe. For its fixed income investments, the firm invests in the debt securities, royalty bonds and other royalty instruments. For its alternative investments, it invests in currencies, index options, and derivatives and also makes private investments in public equity securities. The firm employs a fundamental analysis to make its investments. It primarily invests in healthcare, global health science industry including pharmaceutical, life science, healthcare services, biotechnology, biopharmaceuticals, diagnostics, novel therapies and treatments, health IT, medical device companies, and companies providing services or products that are part of treatments. For its private equity investments, it seeks to invest globally, including North America and Europe; Asia, India, China; and Israel. The firm invests between $3 million and $150 million in its companies. It prefers to take majority stake in companies. OrbiMed Advisors LLC was founded in 1989 and is based in the New York, New York and has additional offices in San Francisco, California; Mumbai, India; Herzliya, Israel; Shanghai, China; West Kowloon, Hong kong and Luxembourg.